Warning letter
Fresenius USA Manufacturing, Inc.: warning letter of Mar 5, 2013
FDA warning letter 393723 · Denver District Office
Key facts
| Reference number | 393723 |
|---|---|
| Company | Fresenius USA Manufacturing, Inc. |
| Subject | CGMP/QSR/Medical Devices/Adulterated |
| Issue date | Mar 5, 2013 |
| Posted date | Mar 5, 2013 |
| Issuing office | Denver District Office |
| Product type | Devices |
| CFR sections cited | 820 |
| Country | 1 |
| Letter on fda.gov | web.archive.org |
At a glance
- 1–9 CFR sections cited
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: